Amphotericin B (Cumberland Emerging Technologies)

两性霉素B (Cumberland Emerging Technologies)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAmphotericin B (Cumberland Emerging Technologies)
Drug Alias Nameamphotericin B (Cumberland Emerging Technologies)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionErgosterol bindersCell membrane permeability enhancers
TargetsErgosterol
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCumberland Emerging Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCumberland Emerging Technologies Inc
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A